ARTL (Artelo Biosciences) OCF Yield %: -207.89 (As of Jun. 26, 2026)


ARTL Artelo Biosciences Inc ARTL
31 GF Score
Price $1.13
! 2 Warning Signs
View Full Analysis

What is Artelo Biosciences OCF Yield %?

Artelo Biosciences ARTL -1.75% 31 OCF Yield % is -207.89 as of Jun. 26, 2026. GuruFocus rates ARTL with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 1,419 Biotechnology companies, Artelo Biosciences ranks worse than 94.71% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Artelo Biosciences's Trailing 12-Month Cash Flow from Operations is $-8.11 Mil, and Market Cap is $3.90 Mil. Therefore, Artelo Biosciences's OCF Yield % for today is -207.89%.

The historical rank and industry rank for Artelo Biosciences's OCF Yield % or its related term are showing as below:

ARTL' s OCF Yield % Range Over the Past 10 Years
Min: -209.29   Med: 0   Max: -200.64
Current: -207.89


During the past 12 years, the highest OCF Yield % of Artelo Biosciences was -200.64%. The lowest was -209.29%. And the median was %.

ARTL's OCF Yield % is ranked worse than
94.71% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs ARTL: -207.89

Artelo Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Artelo Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Artelo Biosciences OCF Yield % Related Terms


Artelo Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Artelo Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artelo Biosciences OCF Yield % Chart

Artelo Biosciences Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.44 -96.82 -184.00 -231.55 -345.89

Artelo Biosciences Quarterly Data
May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -214.60 -21.98 -196.16 -472.72 -71.75

ARTL vs RNAZ, GLMD, DCOY: OCF Yield % Comparison

For the Biotechnology subindustry, Artelo Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artelo Biosciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artelo Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Artelo Biosciences's OCF Yield % falls into.


ARTL
31GF Score
Artelo Biosciences Inc ARTL
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artelo Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Artelo Biosciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-8.52 / 2.46318
=-345.89%

Artelo Biosciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.191 * 4 / 6.64008
=-71.75%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -207.89 mean?
Artelo Biosciences (ARTL) has a OCF Yield % of -207.89 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Artelo Biosciences and its competitors. According to the industry distribution chart, Artelo Biosciences ranks #1344 out of 1419 companies in the Biotechnology industry, placing it in the top 94.7%.
Is Artelo Biosciences' OCF Yield % too high?
Artelo Biosciences' current OCF Yield % is -207.89. Based on the distribution chart, Artelo Biosciences ranks #1344 out of 1419 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Artelo Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Artelo Biosciences' OCF Yield % compare to RNAZ and GLMD?
According to the Biotechnology industry distribution chart, Artelo Biosciences ranks #1344 out of 1419 companies for OCF Yield %. This places Artelo Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Artelo Biosciences and its competitors. Artelo Biosciences's current OCF Yield % is -207.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artelo Biosciences stock overvalued right now?
Artelo Biosciences (ARTL) has a current OCF Yield % of -207.89. The current OCF Yield % is -207.89. Artelo Biosciences' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Artelo Biosciences (ARTL), the current OCF Yield % is -207.89 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artelo Biosciences Business Description

Address 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
31GF Score

Get the complete analysis for ARTL

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price